Objective: The single-minded 1 (SIM1) is a basic helix-loop-helix transcription factor, which plays a critical role in the development of the paraventricular nucleus (PVN) of the hypothalamus. SIM1-deficient mice have a hypocellular PVN and are severely obese with increased food intake. Design: We examined whether variants in the SIM1 gene might be associated with severe early-onset obesity in humans. Two hundred and seventy-seven subjects with hyperphagia and severe, early-onset obesity were screened. Association studies with common single-nucleotide polymorphisms (SNPs) in the SIM1 gene were performed in two population-based cohorts. Results: One novel missense mutation, I128T, was found in one obese subject and not in 192 controls. However, the variant did not co-segregate with obesity in the family. Four SNPs, IVS4 þ 83GA, P352T, A371V and T653T, were also identified. The two common SNPs, P352T and A371V, which are in complete linkage disequilibrium, were genotyped in 981 subjects from a population-based cohort, the Ely Study. An allele frequency of 0.13 was observed. Male subjects carrying the P352T/A371V haplotype were found to have a slightly higher body mass index (BMI; P ¼ 0.038). Female subjects homozygous for the haplotype gained more weight over a period of 4.5 and 10 years (P ¼ 0.003 and P ¼ 0.02, respectively). The association studies were repeated in another population-based cohort, the European Prospective Investigation into Cancer and Nutrition (EPIC) -Norfolk Study with 4869 subjects successfully genotyped. Male subjects homozygous for the P352T/A371V haplotype had slightly higher BMI (P ¼ 0.04). Conclusion: Mutations in SIM1 are not commonly found in humans with severe early-onset obesity. The relationship between the common variants in SIM1 with BMI and body weight gain deserves further exploration in other populations.
Introduction
The mammalian single-minded 1 (SIM1) and single-minded 2 (SIM2) genes are homologues of the Drosophila sim gene, which is a master regulator of fruitfly neurogenesis. The SIM1 protein is a basic helix-loop-helix (bHLH) transcription factor, which is expressed in the developing central nervous system and plays a critical role in the development of the paraventricular nucleus (PVN), anterior periventricular nucleus and supraoptic nucleus (SON) of the hypothalamus, 1 nuclei known to play a role in the regulation of energy homoeostasis. Several additional lines of evidence support SIM1 as a strong candidate gene for human obesity. Mice homozygous for the null Sim1 allele die shortly after birth, and their PVN and SON are hypocellular. 2 Mice heterozygous for the null Sim1 allele have a hypocellular PVN, and are severely obese with increased food intake. 3, 4 In addition, a balanced translocation disrupting the SIM1 gene is associated with severe, early-onset obesity, hyperphagia and increased linear growth in a patient. 5 Although the balanced translocation disrupting the SIM1 gene may be the cause of obesity and hyperphagia in that particular patient, the possibility that altered expression of other genes owing to the chromosome rearrangement might contribute to her phenotype cannot be excluded. Several other cases have been described in which subjects with interstitial 6q deletions encompassing the SIM1 gene present with Prader-Willi-like phenotypes, especially obesity and developmental delay. [6] [7] [8] [9] To investigate whether sequence variations in the SIM1 gene can cause severe obesity in humans, 277 unrelated subjects with hyperphagia and severe, early-onset obesity were selected from the Genetics Of Obesity Study (GOOS) cohort. As several cases with an interstitial 6q deletion encompassing the SIM1 gene were reported to exhibit developmental delay, subjects with phenotypes related to a developmental abnormality were included. Among the 277 subjects studied, 85 had developmental delay. Association studies with common single-nucleotide polymorphisms (SNPs) in the SIM1 gene were performed in 981 subjects from a population-based cohort with height, weight, body mass index (BMI), waist-hip ratio (WHR), weight gain and fasting insulin and glucose levels as outcome variables.
Experimental subjects and procedures

Genetics of Obesity Study
Subjects with severe obesity of early onset (o10 years of age) have been recruited to the UK Genetics of Obesity Study (GOOS). Ninety percent of the cohort is UK Caucasian. BMI (weight in kg/height in m 2 ) standard deviation scores (SDS) were calculated using the UK 1990 growth reference data. 10 The mean BMI SDS of probands is 4.270.8.
The Ely Study
The Ely Study is a prospective population-based cohort study of the aetiology and pathogenesis of type 2 diabetes and related metabolic disorders in UK subjects aged 40-65 years. 11, 12 Follow-up studies, phases 2 and 3, took place 4.5 and 10 years after the initial study, respectively. All subjects were UK Caucasians aged between 40 and 69 years at phase 1.
The European Prospective Investigation into Cancer and Nutrition (EPIC) -Norfolk Study
The EPIC Study was designed to study the relationship between diet and risk of chronic diseases, in particular cancer. We used the EPIC in Norfolk study cohort, comprising 5000 individuals, to examine the relationship between the SIM1 P352T/A371V haplotype and obesity-related phenotypes.
Gene screening and the A371V variant (rs3734355) genotyping The human SIM1 gene (Genbank accession number: NM_005068) is located on chromosome 6q16.3-q21 and consists of 11 exons spanning 75 kb. 13 The 766-amino-acid protein product of the SIM1 gene contains the conserved bHLH, Per/ARNT/Sim (PAS) and hypoxia inducible factor-1 alpha-SIM-Trachealess (HST) domains. The coding region of the human SIM1 gene was screened using 12 pairs of primers. Polymerase chain reaction (PCR) was carried out under standard conditions. Exons were screened by a combination of denaturating high-performance liquid chromatography methods and direct nucleotide sequencing. PCR products were sequenced using BigDye terminator chemistry (PerkinElmer, Foster City, CA, USA) and analysed on an ABI 377 automated DNA sequencer (Perkin-Elmer, Foster City, CA, USA). For the A371V variant genotyping in the Ely Study, the region encompassing the variant was amplified using primers SIM1_9F (5 0 -GAT GAG AGT ATG CAT GAA TCC A-3 0 ) and SIM1_9R (5 0 -AAG TTC AAA CCA TGT CGC CAA A-3 0 ). The PCR products were digested with HaeIII (New England Biolabs, Beverly, MA, USA) and digested fragments were resolved by electrophoresis using 3% (wt/vol) agarose gels. The A371V variant was genotyped in the EPIC -Norfolk Study cohort, using a custom TaqMan assay obtained from Applied Biosystems. The forward and reverse primers 5 0 -CAC CAT GAC TGA CAA CAG AAA GG-3 0 and 5 0 -AAT GCA CTT ACC TGA GGG TAT GG-3 0 amplified the flanking region containing the SNP and the following minor groove binder (MGB) probes were used for allelic discrimination VIC-5 0 -CCG GGA TTT GAC CC-3 0 and FAM-5 0 -CGG GAT TTG GCC C-3 0 . Amplification was performed on 10 ng of wholegenome amplified DNA in a 5 ml 384-well TaqMan assay, using a PTC-225 Thermal Cycler (MJ Research, Watertown, MA, USA), cycling 951C for 10 min, followed by 50 cycles of 921C for 15 s and 601C for 1 min. End-point detection was carried out on an ABI PRISM 7900HT Sequence Detection System.
Statistical analysis
Linkage disequilibrium test was performed using the expectation-maximization algorithm, and Hardy-Weinberg equilibrium test was undertaken using a w 2 'goodness-of-fit' test. The associations between the phenotype and the genotype, adjusted for appropriate covariates, were tested using general linear model in SPSS for Windows 11.0.1. The adjusted means were provided. P-value less than 0.05 was deemed significant.
Results
One novel missense variant I128T (ATT-4ACT) was found in a 5-year-old Caucasian girl with severe, early-onset obesity, hyperphagia and developmental delay (BMI SDS ¼ 4.7). The I128T allele was not found in 192 Caucasian control subjects. I128T is located in the conserved functional PAS-A domain of SIM1 and is conserved in mammalian SIM2 and Drosophila sim ( Figure 1 ). Evidence from nuclear magnetic resonance spectroscopy, mutagenesis studies and domain swapping experiments of related bHLH-PAS transcription factors suggests that the PAS domain mediates and confers specificity for factor dimerization and contributes to the stabilization of the DNA binding conformation. 14 However, family studies showed the I128T allele was inherited from the lean mother (BMI ¼ 23 kg/m 2 ), suggesting that this variant is unlikely to be a monogenic cause of obesity in the proband SIM1 gene in relation to human obesity C-CC Hung et al and more likely to be a rare polymorphism with no significant effects on body weight. Four additional SNPs were identified in subjects from the GOOS cohort. The IVS4 þ 83GA variant, a single-nucleotide change in intron 4, was found in heterozygous form in four (1.8%) subjects, but did not segregate with obesity ( Figure 2 ). The P352T (CCA-4ACA) and A371V (GCC-4GTC) variants are in complete linkage disequilibrium and there are 49 (17.7%) heterozygous and three (1.1%) homozygous carriers. The silent variant, T653T (ACC-4ACT), was found in eight (2.9%) subjects. The majority of the variant carriers are Caucasian. To establish the allele frequencies of these variants in a Caucasian population, 192 subjects from a population-based cohort, the Ely Study, were genotyped for the variants; allele frequencies for the IVS4 þ 83GA, A371V and T653T variants in the Ely Study are 0.021, 0.13 and 0.029 were observed. Having confirmed that P352T and A371V are common polymorphisms, we went on to investigate if these common SNPs were associated with obesity-related traits. Nine hundred and eighty-one non-diabetic subjects from the population-based cohort, the Ely Study, were genotyped for the A371V variant using HaeIII restriction fragment length polymorphism assays. The distribution of genotypes is consistent with the Hardy-Weinberg prediction. The traits examined included height, weight, BMI, WHR, weight gain and fasting insulin and glucose levels. The male carriers for SIM1 gene in relation to human obesity C-CC Hung et al the P352T/A371V haplotype have a slightly higher mean BMI, compared to the others (P ¼ 0.038) ( Table 1) . No significant association between the A371V variant with any obesity-related traits was detected in women (Table 1) . Utilizing a recessive model, individuals homozygous for the P352T/A371V haplotype appear to have slightly lower BMIs, although this does not reach statistical significance (P ¼ 0.805 and P ¼ 0.215 in men and women, respectively). In contradiction to these results, female homozygous subjects for the P352T/A371V haplotype appear to have gained more weight over an averaged period of 4.5 and 10 years (P ¼ 0.003 and P ¼ 0.02, respectively; Table 2 ).
To further explore the relationships between the P352T/ A371V haplotype and obesity-related traits, including weight, height, BMI and WHR, the association studies were repeated in a larger Caucasian cohort, EPIC -Norfolk Study.
Four thousand eight hundred and sixty-nine subjects from the population-based cohort, the EPIC -Norfolk, were genotyped for the A371V variant, using Taqman 5 0 exo nuclease assays. The distribution of genotypes did not deviate significantly from the Hardy-Weinberg prediction. Male subjects homozygous for the P352T/A371V haplotype have slightly higher BMI (P ¼ 0.04; Table 3 ). No significant associations between the P352T/A371V haplotype with any obesity-related traits were detected in women (Table 3) .
Discussion
We identified a novel variant in SIM1 in a severely obese patient; however, the I128T allele was inherited from the lean mother and as such this variant is unlikely to be a b Weight, height, BMI and waist-hip ratio were adjusted for age, whereas other parameters were adjusted for age and BMI. SIM1 gene in relation to human obesity C-CC Hung et al monogenic cause of obesity in the proband. We also identified two common polymorphisms P352T and A371V located in the C-terminal of SIM1 (Figure 1 ). No specific domain in the C-terminal half of SIM1 has been characterized. In addition, the C-terminal half of the Drosophila sim, mammalian SIM1 and SIM2 are not homologous. Whereas it is generally agreed that the C-terminal of SIM2 has a transcription repressive function, the function of the SIM1 Cterminal remains elusive. Several genome-wide scans in various populations have showed a strong linkage of the loci on chromosome 6q for obesity-and type 2 diabetesrelated traits. Atwood et al. 15 reported a peak of linkage between 6q23 and 25 with BMI in the Framingham Heart Study. The locus on 6q22.31-23.2 was found to associate with childhood obesity in French families. 16 Duggirala et al. 17 showed strong linkage between 6q16.1 and 24.1 and serum leptin and plasma insulin concentrations in Mexican Americans. Markers on 6q have been associated with insulin levels in Hutterite pedigrees, 18 and with type 2 diabetes susceptibility in Finish and American populations. 19, 20 The SIM1 gene is one of the candidate genes within the confidence interval of the above linkages. To this end, common polymorphisms in the SIM1 gene might contribute to these linkages directly through influences on protein function or indirectly through linkage disequilibrium with other functional variants. Our studies showed associations between the P352T/A371V haplotype and BMI in men with borderline significances in two populations, whereas female subjects homozygous for the P352T/A371V haplotype were found to gain more weight over an averaged period of 4.5 and 10 years. Further investigation using larger populations would be required to confirm these associations and shed further light on the contribution of SIM1 variants to these traits. Weight, height, BMI and waist-hip ratio were adjusted for age, whereas other parameters were adjusted for age and BMI.
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